Literature DB >> 8546037

Biological and genetic analysis of a longitudinal collection of Giardia samples derived from humans.

J A Upcroft1, P F Boreham, R W Campbell, R W Shepherd, P Upcroft.   

Abstract

Duodenal aspirates from children investigated for diarrhoea have been examined for the presence of Giardia over an eleven year period, and where possible, in vitro or in vivo Giardia cultures in mice were established. Based on biochemical characteristics of electrophoretic karyotype, RFLP analysis and rDNA hybridization studies of 40 stocks at least two major varieties, or demes, of Giardia have infected the population of South East Queensland and environs during this period. These demes carried different rDNA repeat units and differed markedly in both the electrophoretic karyotype pattern and the molar representation of chromosome bands. From 1983 to 1991 only one deme was documented. The first evidence of a new deme seen in local children occurred in 1991 and was followed by a predominance of this deme in 1993. These 40 stocks do not represent all positive samples. Other stocks established in vivo were not able to be cultured in vitro, and these probably represent other demes. Since all of the stocks established in vivo were not able to be cultured in vitro, and these probably represent other demes. Since all of the stocks were derived from children with similar chronic symptoms it appears that at least two demes of Giardia are pathogenic.

Entities:  

Mesh:

Substances:

Year:  1995        PMID: 8546037     DOI: 10.1016/0001-706x(95)00100-s

Source DB:  PubMed          Journal:  Acta Trop        ISSN: 0001-706X            Impact factor:   3.112


  12 in total

1.  A new-generation 5-nitroimidazole can induce highly metronidazole-resistant Giardia lamblia in vitro.

Authors:  Linda A Dunn; Anita G Burgess; Kenia G Krauer; Lars Eckmann; Patrice Vanelle; Maxime D Crozet; Frances D Gillin; Peter Upcroft; Jacqueline A Upcroft
Journal:  Int J Antimicrob Agents       Date:  2010-04-24       Impact factor: 5.283

2.  Drug susceptibility testing of anaerobic protozoa.

Authors:  J A Upcroft; P Upcroft
Journal:  Antimicrob Agents Chemother       Date:  2001-06       Impact factor: 5.191

3.  Sequence map of the 3-Mb Giardia duodenalis assemblage A chromosome.

Authors:  Jacqueline A Upcroft; Kenia G Krauer; Anita G Burgess; Linda A Dunn; Nanhua Chen; Peter Upcroft
Journal:  Chromosome Res       Date:  2009-10-16       Impact factor: 5.239

Review 4.  Chromosome sequence maps of the Giardia lamblia assemblage A isolate WB.

Authors:  Jacqui A Upcroft; Kenia G Krauer; Peter Upcroft
Journal:  Trends Parasitol       Date:  2010-08-24

Review 5.  Drug targets and mechanisms of resistance in the anaerobic protozoa.

Authors:  P Upcroft; J A Upcroft
Journal:  Clin Microbiol Rev       Date:  2001-01       Impact factor: 26.132

6.  First record of Giardia in cattle in Denmark.

Authors:  T Iburg; R B Gasser; S A Henriksen
Journal:  Acta Vet Scand       Date:  1996       Impact factor: 1.695

7.  Barcoding of Giardia duodenalis isolates and derived lines from an established cryobank by a mutation scanning-based approach.

Authors:  Matthew J Nolan; Aaron R Jex; Jacqui A Upcroft; Peter Upcroft; Robin B Gasser
Journal:  Electrophoresis       Date:  2011-08       Impact factor: 3.535

8.  A reprofiled drug, auranofin, is effective against metronidazole-resistant Giardia lamblia.

Authors:  Noa Tejman-Yarden; Yukiko Miyamoto; David Leitsch; Jennifer Santini; Anjan Debnath; Jiri Gut; James H McKerrow; Sharon L Reed; Lars Eckmann
Journal:  Antimicrob Agents Chemother       Date:  2013-02-12       Impact factor: 5.191

9.  A novel in vitro image-based assay identifies new drug leads for giardiasis.

Authors:  Christopher J S Hart; Taylah Munro; Katherine T Andrews; John H Ryan; Andrew G Riches; Tina S Skinner-Adams
Journal:  Int J Parasitol Drugs Drug Resist       Date:  2017-01-27       Impact factor: 4.077

10.  Data from a proteomic baseline study of Assemblage A in Giardia duodenalis.

Authors:  Samantha J Emery; Ernest Lacey; Paul A Haynes
Journal:  Data Brief       Date:  2015-08-19
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.